Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided ...

Rivals Sun Pharma and Cipla beat third-quarter profit estimates, while Dr Reddy's missed expectations. All three drugmakers ...

Pharma stocks had a mixed response after Finance Minister Nirmala Sitharaman announced customs duty exemptions for 36 ...

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

Tata Consumer Products expands food services and pharmacy channels nationwide, leveraging strong product portfolio post ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...

Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

The Union Budget 2025 presents an opportunity to propel this sector toward innovation, self-reliance, and global ...

Tata Power, Hero MotoCorp, OneSource Speciality Pharma, CL Educate, Aurobindo Pharma, Waaree Energies, KPI Energy, Nestle ...